<bill session="108" type="h" number="1733" updated="2023-01-15T23:18:05Z">
  <state datetime="2003-04-10">REFERRED</state>
  <status>
    <introduced datetime="2003-04-10"/>
  </status>
  <introduced datetime="2003-04-10"/>
  <titles>
    <title type="display">Senior Bill of Rights Act of 2003</title>
    <title type="official" as="introduced">To amend XVIII and XIX of the Social Security Act to provide for a voluntary Medicare prescription medicine benefit, to provide greater access to affordable pharmaceuticals, to provide for substantial reductions in the cost of prescription drugs made available to Medicare beneficiaries, to amend the Internal Revenue Code of 1986 to disallow deductions for direct-to-consumer advertisement of prescription drugs, to amend the Federal Food, Drug, and Cosmetic Act to provide greater access to affordable pharmeceuticals and preserving access to safe affordable Canadian medicines, to amend the Federal Election Campaign Act of 1971 to prohibit campaign contributions by chief executive officers of pharmeceutical companies, and for other purposes.</title>
    <title type="short" as="introduced">Senior Bill of Rights Act of 2003</title>
    <title type="short" as="introduced" partial="1">Greater Access to Affordable Pharmaceuticals Act of 2003</title>
    <title type="short" as="introduced" partial="1">Prescription Drug Fairness for Seniors Act of 2003</title>
    <title type="short" as="introduced" partial="1">Preserving Access to Safe Affordable Canadian Medicines Act of 2003</title>
  </titles>
  <sponsor bioguide_id="C001038"/>
  <cosponsors>
    <cosponsor bioguide_id="A000357" joined="2003-04-10"/>
    <cosponsor bioguide_id="F000392" joined="2003-04-10"/>
    <cosponsor bioguide_id="G000551" joined="2003-06-03"/>
    <cosponsor bioguide_id="I000057" joined="2003-05-01"/>
    <cosponsor bioguide_id="K000009" joined="2003-04-10"/>
    <cosponsor bioguide_id="K000172" joined="2003-04-10"/>
    <cosponsor bioguide_id="M000590" joined="2003-04-10"/>
    <cosponsor bioguide_id="O000159" joined="2003-04-29"/>
    <cosponsor bioguide_id="R000053" joined="2003-04-29"/>
    <cosponsor bioguide_id="S000033" joined="2003-04-10"/>
  </cosponsors>
  <actions>
    <action datetime="2003-04-10">
      <text>Introduced in House</text>
    </action>
    <action datetime="2003-04-10" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Veterans' Affairs, and House Administration, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2003-04-10">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Veterans' Affairs, and House Administration, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2003-04-10">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Veterans' Affairs, and House Administration, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2003-04-10">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Veterans' Affairs, and House Administration, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2003-04-23">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2003-04-24">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2003-05-21">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSVR" name="House Veterans' Affairs" subcommittee="" activity="Referral"/>
    <committee code="HSVR03" name="House Veterans' Affairs" subcommittee="Health" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
    <committee code="HSHA" name="House Committee on House Administration" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Access to health care"/>
    <term name="Administrative procedure"/>
    <term name="Administrative remedies"/>
    <term name="Antibiotics"/>
    <term name="Armed Forces and National Security"/>
    <term name="Auditing"/>
    <term name="Business records"/>
    <term name="Campaign funds"/>
    <term name="Canada"/>
    <term name="Chief executive officers"/>
    <term name="Civil Rights and Liberties, Minority Issues"/>
    <term name="Civil actions and liability"/>
    <term name="Coinsurance"/>
    <term name="Commerce"/>
    <term name="Competition"/>
    <term name="Competitive bidding"/>
    <term name="Congress"/>
    <term name="Congressional elections"/>
    <term name="Congressional reporting requirements"/>
    <term name="Consumer complaints"/>
    <term name="Consumer discounts"/>
    <term name="Cost control"/>
    <term name="Costs"/>
    <term name="Department of Health and Human Services"/>
    <term name="Disabled"/>
    <term name="Drug advertising"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Drug interactions"/>
    <term name="Drugs"/>
    <term name="Economics and Public Finance"/>
    <term name="Employee health benefits"/>
    <term name="Federal advisory bodies"/>
    <term name="Federal aid to research"/>
    <term name="Finance and Financial Sector"/>
    <term name="Fines (Penalties)"/>
    <term name="Foreign Trade and International Finance"/>
    <term name="Generic drugs"/>
    <term name="Government Operations and Politics"/>
    <term name="Government contractors"/>
    <term name="Government paperwork"/>
    <term name="Government publicity"/>
    <term name="Government trust funds"/>
    <term name="Governmental investigations"/>
    <term name="Health care fraud"/>
    <term name="Health education"/>
    <term name="Health insurance"/>
    <term name="Health insurance continuation"/>
    <term name="Health maintenance organizations"/>
    <term name="Imports"/>
    <term name="Income tax"/>
    <term name="Indexing (Economic policy)"/>
    <term name="Injunctions"/>
    <term name="Insulin"/>
    <term name="Insurance premiums"/>
    <term name="Intellectual property"/>
    <term name="Labor and Employment"/>
    <term name="Latin America"/>
    <term name="Law"/>
    <term name="Managed care"/>
    <term name="Medicaid"/>
    <term name="Medical economics"/>
    <term name="Medical records"/>
    <term name="Medicare"/>
    <term name="Medigap"/>
    <term name="Mexico"/>
    <term name="Old age, survivors and disability insurance"/>
    <term name="Patent infringement"/>
    <term name="Patents"/>
    <term name="Patient satisfaction"/>
    <term name="Pharmaceutical research"/>
    <term name="Pharmacies"/>
    <term name="Prescription pricing"/>
    <term name="Presidential elections"/>
    <term name="Price discrimination"/>
    <term name="Quality of care"/>
    <term name="Rebates"/>
    <term name="Research and development"/>
    <term name="Research grants"/>
    <term name="Restrictive trade practices"/>
    <term name="Retiree health benefits"/>
    <term name="Right of petition"/>
    <term name="Right of privacy"/>
    <term name="Science, Technology, Communications"/>
    <term name="Social Welfare"/>
    <term name="Social security finance"/>
    <term name="Standards"/>
    <term name="Tax deductions"/>
    <term name="Tax rates"/>
    <term name="Taxation"/>
    <term name="Telephone"/>
    <term name="Terminal care"/>
    <term name="Veterans' medical care"/>
  </subjects>
  <amendments/>
  <summary date="2006-11-28T17:35:40Z" status="Introduced in House">Senior Bill of Rights Act of 2003 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to provide for a voluntary Medicare outpatient prescription medicine benefit program with a monthly premium of $25, a $100 annual deductible, 20 percent coinsurance, and an annual out-of-pocket spending limit of $2,000. Directs the Secretary of Health and Human Services to negotiate for maximum prices with medicine manufacturers.Establishes a Medicare Prescription Medicine Advisory Committee.Amends SSA title XVIII part C (Medicare+Choice) to require Medicare+Choice organizations to make actuarially equivalent outpatient prescription medicines available under their plans. Requires Medigap policies also to cover such medicines. Provides for transitional assistance to low-income beneficiaries.Prescription Drug Fairness for Seniors Act of 2003 - Requires each participating manufacturer to make covered outpatient drugs available at a price no greater than the manufacturer's average foreign price. Declares the sense of Congress that the cost disparity between identical prescription drugs sold in the United States, Canada, and Mexico should be reduced or eliminated.Amends the Internal Revenue Code to disallow any deduction for any amount paid or incurred for a direct-to-consumer advertisement of a prescription drug.Greater Access to Affordable Pharmaceuticals Act of 2003 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) with respect to: (1) abbreviated new generic drug applications, including forfeit to the next applicant by previous applicants who fail to market a drug within 90 days of approval or meet other specified requirements; (2) specified bioequivalence tests other than those for absorption rate and extent assessment; (3) requirements for citizen petitions regarding new drug applications; (4) actions for patent infringement; and (5) requirements for new drug applications, including mandatory patent information.Preserving Access to Safe Affordable Canadian Medicines Act of 2003 - Amends FFDCA to prohibit prescription medication manufacturers from taking actions to discriminate against, or cause other persons to discriminate against, U.S. consumers regarding the purchase of prescription medications from Canadian pharmacies.Prohibits the Commissioner of Food and Drugs from approving any new drug application that does not, before completion of the approval process, provide the Secretary a written statement specifying the total cost of research and development with respect to such drug.Amends the Federal Election Campaign Act of 1971 to prohibit the chief executive officer of a pharmaceutical company from contributing to a political party or candidate.Rescinds the February 2002 veterans medication copayment increase, and reinstates the $2 copayment.Declares that all Social Security and Medicare funds shall be walled off into a lock box that may not be raided for new programs or tax cuts for the rich.</summary>
</bill>
